ASVRX | CSVRX | ASVRX / CSVRX | |
Total Expense Ratio | 1.58 | 1.45 | 109% |
Annual Report Gross Expense Ratio | 1.58 | 1.48 | 107% |
Fund Existence | 16 years | 15 years | - |
Gain YTD | -6.492 | 5.574 | -116% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.09B | 1.82B | 225% |
Annual Yield % from dividends | 0.41 | 0.64 | 65% |
Returns for 1 year | -13.88 | 3.69 | -376% |
Returns for 3 years | 8.87 | 26.45 | 34% |
Returns for 5 years | 40.55 | 44.09 | 92% |
Returns for 10 years | 10.25 | 9.32 | 110% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GFVCX | 15.47 | 0.09 | +0.59% |
Goldman Sachs Focused Value C | |||
ECTVX | 41.46 | 0.15 | +0.36% |
Eaton Vance Tx-Mgd Value C | |||
SBFIX | 22.65 | 0.01 | +0.04% |
Federated Hermes Global Allocation IS | |||
HLGEX | 55.31 | -0.11 | -0.20% |
JPMorgan Mid Cap Growth I | |||
VGPMX | 18.89 | -0.18 | -0.94% |
Vanguard Global Capital Cycles Investor |